Tirzepatide during Ramadan in people with obesity without diabetes: A critical knowledge gap

Key Points

• Assess the effects of Tirzepatide in individuals with obesity during Ramadan, focusing on those without diabetes.
• Evaluation of Tirzepatide intervention during Ramadan fasting period.
• Population included individuals with obesity not diagnosed with diabetes.
• Identified critical knowledge gaps regarding Tirzepatide's impact in the fasting context.
• Highlighted potential implications for managing obesity during Ramadan.